InsightfulValue
← Home

Amgen
Amgen

-8.01%

Healthcare & biotech / Biotechnology and Pharmaceuticals


πŸ”§ Tools

βœ… Due Diligence
🧩 Revenue Segmentation by Product

Switch to Location
Fiscal year Segment Value
2024 Aranesp 1.34B
2024 BLINCYTO 1.22B
2024 ENBREL 3.32B
2024 Prolia 4.37B
2024 TEPEZZA 1.85B
2024 EVENITY 1.56B
2024 TEZSPIRE 972M
2024 Otezla 2.13B
2024 Repatha (evolocumab) 2.22B
Amgen

πŸ’° Explore more revenue segmentation data for Amgen!

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal